Search details
1.
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
Clin Infect Dis
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38598658
2.
Revisiting Co-trimoxazole Prophylaxis for African Adults in the Era of Antiretroviral Therapy: A Randomized Controlled Clinical Trial.
Clin Infect Dis
; 73(6): 1058-1065, 2021 09 15.
Article
in English
| MEDLINE | ID: mdl-33744963
3.
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 Years.
Ophthalmology
; 128(10): 1460-1468, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33798654
4.
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
Ophthalmology
; 126(9): 1273-1285, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31443789
5.
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Lancet
; 390(10097): 849-860, 2017 Aug 26.
Article
in English
| MEDLINE | ID: mdl-28712537
6.
Protection against Plasmodium falciparum malaria by PfSPZ Vaccine.
JCI Insight
; 2(1): e89154, 2017 01 12.
Article
in English
| MEDLINE | ID: mdl-28097230
Results
1 -
6
de 6
1
Next >
>>